Tokyo, June 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061894) titled 'Development of a New Evaluation Method to Remove Image Noise and Detect Heart Disease Accurately' on June 15.
Study Type:
Observational
Primary Sponsor:
Institute - Ibaraki Prefectural University of Health Sciences
Condition:
Condition - cardiac amyloidosis
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - The objective of this study is to evaluate the impact of background activity in the lungs and blood pool on the heart-to-contralateral lung (H/CL) ratio in 99mTc-HMDP SPECT, utilizing quantitative Monte Carlo simulations.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Male
Key inclusion criteria - Adult patients who underwent nuclear medicine examinations using 99mTc-HMDP.
Key exclusion criteria - Patients with significant image artifacts (e.g., severe patient motion) that hinder analysis.
Patients with suspected non-specific uptake of bone-seeking tracers due to a history of acute myocardial infarction within the previous 6 months, severe active myocarditis, chest trauma, or prior chest radiation therapy.
Target Size - 50
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 06 Month 12 Day
Anticipated trial start date - 2026 Year 07 Month 02 Day
Last follow-up date - 2027 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070780
Disclaimer: Curated by HT Syndication.
